JYSB2200018 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2022-02-11 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | | | view |
JYSZ2400033 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd | | | view |
JYSB2400206 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
JYSB2300156 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2023-09-12 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | | | view |
JYSB2400207 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
JYSB2300155 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2023-09-12 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | | | view |
JYSB2400191 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-08-26 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | | | view |
JTS2200110 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2022-12-31 | | Roche Müstehtarlar Sanayi Anonim;Shanghai Fosun Pharmaceutical Industrial Development Co Ltd;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
JYSB2400190 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-08-26 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
JYSB2200017 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2022-02-11 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
JYSZ2400034 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd | | | view |
JTS1900039 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2019-08-03 | 瑞士罗氏制药有限公司 F. Hoffman-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland);TOT Biopharm Co Ltd;Roche Registration GmbH | Certificate Issued | 2019-09-04 | view |
JTS1900038 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Disposable Import Drug Application | 2019-08-03 | 瑞士罗氏制药有限公司F. Hoffman-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland);TOT Biopharm Co Ltd;Roche Registration GmbH | Certificate Issued | 2019-09-04 | view |
JXSS1900012 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-03-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Certificate Issued | 2020-01-22 | view |
JXSS1900013 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2019-03-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2020-01-22 | view |
JYSB2000158 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-05-15 | view |
JYSB2000157 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-05-15 | view |
JYSB2000194 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Filed | 2020-05-25 | view |
JYSB2000193 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2020-05-16 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | Filed | 2020-05-25 | view |
JXSS2000016 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Import Drug Application | 2020-05-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | In Review | 2020-05-26 | view |